MedTrace Logo

Boramae Hospital Liver Cirrhosis Patient Cohort Study

NCT01943318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-04-12

No results posted yet for this study

Summary

Liver cirrhosis represents a worldwide health problem and is a major cause of mortality. Cirrhosis is the common end for chronic alcohol abuse and hepatitis C and B virus infections. Patients who have cirrhosis have varying degrees of compensated liver function, and clinicians need to differentiate between those who have stable, compensated cirrhosis and those who have decompensated cirrhosis. It is shown various complications: portal hypertension, hepatocellular carcinoma, hepato-renal syndrome, etc.

Thus, it is important to have this information to manage disease and determine specific therapy. However, register-based studies in have not been reported in Korea.

The goal of this study is to describe the natural history of a large number of patients with liver cirrhosis prospectively followed, and to identify predictors of the occurrence of Hepatocellular carcinoma.

Conditions

Interventions

PROCEDURE

Liver biopsy

Histologic evaluation

DEVICE

Hepatic venous pressure gradient (HVPG) measurement

Hepatic venous pressure gradient (HVPG) measurement

Sponsors & Collaborators

  • Seoul National University Boramae Hospital

    lead OTHER

Principal Investigators

  • Won Kim, MD · Boramae Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943318 on ClinicalTrials.gov